FDMT
4D Molecular Therapeutics Inc.
Company Overview
| Mkt Cap | $559.03M | Price | $11.50 |
| Volume | 1.11M | Change | +1.59% |
| P/E Ratio | -3.5 | Open | $11.95 |
| Revenue | $37.0K | Prev Close | $11.32 |
| Net Income | $-160.9M | 52W Range | $2.24 - $12.34 |
| Div Yield | N/A | Target | $31.13 |
| Overall | 64 | Value | 60 |
| Quality | 50 | Technical | 83 |
No chart data available
Stock Overview
Updated Daily4D Molecular Therapeutics Inc. (FDMT) is a leading Manufacturing company in the Biological Product (except Diagnostic) Manufacturing industry, currently trading at $11.50 with a market capitalization of $559.03 million. The stock is trading near its 52-week highs, indicating strong momentum, demonstrating average quality indicators with a MarketXLS quality score of 50.
Today's trading session shows FDMT with a volume of 1.11 million shares. The stock opened up 5.57% from yesterday's close of $11.32. Current analyst estimates project earnings of $-3.74 per share for this year, with next year targeting $-3.88.
FDMT demonstrates very strong technical momentum based on technical analysis. The company trades on the NGS exchange and operates alongside industry peers including OTIC, OTLC, OVAT-CA, ORTH-CA.
Key investment considerations for FDMT include solid overall investment characteristics. The company offers a dividend yield of NA% and analyst price targets suggest potential upside of 170.7%. The stock shows fair valuation metrics based on valuation analysis.
Analysis generated on November 3, 2025 at 11:12 AM
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | FDMT | $11.50 | +1.6% | 1.11M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get 4D Molecular Therapeutics Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW